Publications by authors named "Shujing Xiao"

Claim this Profile
A
Acupuncture combined with opioids for cancer pain: a pilot pragmatic randomized controlled trial.
Yihan He, Haibo Zhang, Yifang Li, Shunqin Long, Shujing Xiao

Acupunct Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Corrigendum] Traditional Chinese medicine, Fuzheng Kang‑Ai decoction, inhibits metastasis of lung cancer cells through the STAT3/MMP9 pathway.
Longmei Li, Sumei Wang, Xiaobin Yang, Shunqin Long, Shujing Xiao

Mol Med Rep· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fuzheng Kang-Ai decoction enhances the effect of Gefitinib-induced cell apoptosis in lung cancer through mitochondrial pathway.
Sumei Wang, Zhiwei Peng, Wenjuan Li, Shunqin Long, Shujing Xiao

Cancer Cell Int· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gefitinib plus Fuzheng Kang'ai Formula () in Patients with Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation: A Randomized Controlled Trial.
Xiao-Bing Yang, Xiao-Shu Chai, Wan-Yin Wu, Shun-Qin Long, Hong Deng, Shu-Jing Xiao

Chin J Integr Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decoction of Chinese Herbal Medicine Fuzheng Kang-Ai Induces Lung Cancer Cell Apoptosis via STAT3/Bcl-2/Caspase-3 Pathway.
Sumei Wang, Shunqin Long, Shujing Xiao, Wanyin Wu, Swei Sunny Hann

Evid Based Complement Alternat Med· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Traditional Chinese medicine, Fuzheng Kang‑Ai decoction, inhibits metastasis of lung cancer cells through the STAT3/MMP9 pathway.
Longmei Li, Sumei Wang, Xiaobin Yang, Shunqin Long, Shujing Xiao

Mol Med Rep· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Combination of Jianpi Liqi Yiliu Formula with Cytokine-induced Killer Cell Treatment for Advanced Hepatocellular Carcinoma].
Shun-qin Long, Xiao-xuan Zhang, Xiao-bing Yang, Yu-shu Zhou, Wen-feng He, Shu-jing Xiao

Zhongguo Zhong Xi Yi Jie He Za Zhi· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial.
Xiao-Bing Yang, Wan-Yin Wu, Shun-Qin Long, Hong Deng, Zong-Qi Pan, Shu-Jing Xiao

Trials· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The distribution of Chinese medicine syndrome types in primary liver cancer and their differences of the survival time: a clinical study].
Xiao-Bing Yang, Shun-Qin Long, Wan-Yin Wu, Hong Deng, Zong-Qi Pan, Shu-Jing Xiao

Zhongguo Zhong Xi Yi Jie He Za Zhi· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis